Newsroom

The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Clinical Practice Guidelines in Oncology™ for Breast Cancer Screening and Diagnosis and continues to recommend annual clinical breast examinations and mammography for women 40 years and older at normal risk.    Read more

Advanced screening methods for colon cancer, which can pick out pre-cancer years before a cancerous condition develops, are leading physicians to question the standard treatment options – which includes surgical removal of the entire colon, a procedure that can worsen a healthy patient’s quality of life.    Read more

A new study has documented a nine-fold higher risk of pancreatic cancer in individuals with Lynch syndrome, a rare genetic cancer predisposition syndrome, report scientists from the Dana-Farber Cancer Institute and the University of Michigan Comprehensive Cancer Center. Carriers of the Lynch syndrome gene mutations have an 80 percent risk of colorectal cancer beginning at a young age, as well as an array of other cancers of the digestive system, brain and skin, and endometrium and ovaries in women.    Read more

While it is a known fact that smoking can lead to lung cancer, non-smokers can develop lung cancer too. Secondhand smoke, being exposed to arsenic, asbestos, radioactive dust, or radon can all increase your chances of getting lung cancer. People who are exposed to radiation at work or elsewhere also have a higher chance of getting lung cancer.    Read more

Researchers at the University of Michigan Comprehensive Cancer Center have discovered what leads to two genes fusing together, a phenomenon that has been shown to cause prostate cancer to develop. The study found that pieces of chromosome relocate near each other after exposure to the hormone androgen. This sets the scene for the gene fusion to occur.    Read more

A clinical trial for women with an aggressive form of metastatic breast cancer will open soon at the University of Michigan Comprehensive Cancer Center in Ann Arbor and is now open at Beaumont Hospital, Royal Oak, the only sites in the state to be designated as study locations. The trial features a novel drug that is seen as a significant breakthrough in the treatment of triple negative breast cancer or TNBC.    Read more

Arul Chinnaiyan, M.D., Ph.D. (pictured), director of the Michigan Center for Translational Pathology; and Ana Diez Roux, M.D., Ph.D., M.P.H., professor of epidemiology, director of the Center for Integrative Approaches to Health Disparities have been have been elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine.    Read more

Between 3% and 35% of cancer deaths could be avoided through screening. But, even though most screening tests are noninvasive or minimally invasive, some do present small risks of serious complications. Some tests can produce false-positives, which may lead to anxiety and unnecessary invasive diagnostic procedures.    Read more